1 Min Read
* Pavmed reports third quarter 2017 financial results
* Q3 GAAP loss per share $0.40
* Q3 adjusted non-GAAP loss per share $0.13 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.